Aquestive Therapeutics AQST
NASDAQ AQST
$4.57 +0.13 (+2.93%)
As of: Oct 2, 2026 · 10:02 AM EDT

Aquestive Therapeutics (AQST) Return on Equity [ROE] (2018 - 2019)

Updated

Aquestive Therapeutics' Return on Equity [ROE] came in at -3347.45% for FY2019.

Analysis

Aquestive Therapeutics (AQST) Return on Equity [ROE] (2018 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Aquestive Therapeutics 581.12 Mn 121.66 Mn 9.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 -3,986.13%
Dec 31, 2018 -366.16%
API Access

Aquestive Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AQST&period=max&api_key=YOUR_API_KEY